Atrás
Rango del Día
$17.07
$18.04
Rango de 52 Semanas
$6.36
$25.00
Volumen
1,896,847
Promedio 50D / 200D
$17.04
/
$15.45
Cierre Anterior
$17.87
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -6.6 | 0.3 |
| P/B | 3.0 | 2.9 |
| ROE % | -55.7 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$37.60
+110.6%
Low: $23.00
High: $60.00
EPS Futuro
-$3.16
Ingresos Est.
1 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$2.17
-$0.14 – $8.13
|
1.4 B | 3 |
| FY2029 |
-$0.27
-$1.01 – $0.02
|
850 M | 3 |
| FY2028 |
-$2.27
-$5.73 – $0.61
|
300 M | 9 |
Puntos Clave
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -405.13M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-55.71%
ROIC-35.38%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.02
Current Ratio22.25
Interest Coverage-75.61
Valoración
P/E Ratio
-6.60
P/B Ratio3.03
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -446.21M |
| ROE | -55.71% | ROA | -37.59% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -405.13M |
| ROIC | -35.38% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 22.25 |
| Interest Coverage | -75.61 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.60 | P/B Ratio | 3.03 |
| P/S Ratio | N/A | PEG Ratio | -1.90 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.95B | Enterprise Value | 2.07B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -446.21M | -317.42M | -235.94M | -168.10M | -149.29M |
| EPS (Diluted) | -3.47 | -3.37 | -3.95 | -3.23 | -2.93 |
| Gross Profit | -2.05M | -2.24M | -2.46M | 0.0 | 0.0 |
| Operating Income | -468.18M | -343.89M | -242.16M | -170.96M | -150.03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.19B | 691.23M | 165.08M | 306.33M | 425.66M |
| Total Liabilities | 214.83M | 61.40M | 73.79M | 53.96M | 57.47M |
| Shareholders' Equity | 972.13M | 629.84M | 91.29M | 252.36M | 368.20M |
| Total Debt | 20.28M | 23.99M | 27.42M | 30.48M | 32.64M |
| Cash & Equivalents | 893.37M | 435.45M | 121.63M | 172.15M | 200.83M |
| Current Assets | 1.13B | 659.28M | 129.38M | 265.59M | 382.39M |
| Current Liabilities | 50.63M | 42.26M | 51.10M | 28.09M | 28.72M |